Lennox Gastaut Syndrome News and Research

RSS
Lennox-Gastaut syndrome (LGS) is a severe type of epilepsy characterized by many types of seizures, mainly drop and stiffening seizures. LGS can be a result of malformations in the brain, head injury, perinatal asphyxia, infection in the central nervous system, and inherited metabolic or degenerative disorders.
Lundbeck announces availability of ONFI Tablets in the U.S.

Lundbeck announces availability of ONFI Tablets in the U.S.

Lundbeck's ONFI receives FDA approval for treating seizures associated with Lennox-Gastaut syndrome

Lundbeck's ONFI receives FDA approval for treating seizures associated with Lennox-Gastaut syndrome

FDA accepts Lundbeck's clobazam NDA for review

FDA accepts Lundbeck's clobazam NDA for review

Eisai receives FDA approval for BANZEL Oral Suspension to treat seizures linked with LGS

Eisai receives FDA approval for BANZEL Oral Suspension to treat seizures linked with LGS

Lundbeck reports positive phase III study data of clobazam in treating seizures associated with LGS

Lundbeck reports positive phase III study data of clobazam in treating seizures associated with LGS

Eisai's NDA for BANZEL Oral Suspension accepted for FDA review

Eisai's NDA for BANZEL Oral Suspension accepted for FDA review

Studies suggest potent therapeutic effects of rufinamide in bipolar disorder, depressive and anxiety disorders

Studies suggest potent therapeutic effects of rufinamide in bipolar disorder, depressive and anxiety disorders

PhRMA President honors Ron and Raychel Bartek for driving awareness of Friedreich's ataxia

PhRMA President honors Ron and Raychel Bartek for driving awareness of Friedreich's ataxia

New educational program for caregivers of patients with Lennox-Gastaut syndrome

New educational program for caregivers of patients with Lennox-Gastaut syndrome

"Helmets for Hope" campaign launched to raise epilepsy disorder awareness

"Helmets for Hope" campaign launched to raise epilepsy disorder awareness

FDA approves Banzel (rufinamide) for Lennox-Gastaut syndrome

FDA approves Banzel (rufinamide) for Lennox-Gastaut syndrome

Ovation Pharmaceuticals advances development pipeline with new phase III epilepsy study

Ovation Pharmaceuticals advances development pipeline with new phase III epilepsy study

Tentative approval for Topiramate Tablets

Tentative approval for Topiramate Tablets